22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review
Go back to 22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review| 22ND CENTURY GROUP, Inc. (NASDAQ: XXII) | Delayed: 4.37 -0.27 (5.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.64 | 52 Week High | $1.71 | |||
| Open | $4.59 | 52 Week Low | $0.71 | |||
| Day High | $4.59 | P/E | N/A | |||
| Day Low | $4.25 | EPS | $-0.60 | |||
| Volume | 18,454 | |||||
